Global Companion Diagnostics (CDx) Development Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 126
Published Date: 02 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Companion Diagnostics (CDx) Development Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Companion Diagnostics (CDx) Development Services industry chain, the market status of Infectious Diseases (Feasibility Studies, Assay Development), Neurological Disorders (Feasibility Studies, Assay Development), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Companion Diagnostics (CDx) Development Services.
Regionally, the report analyzes the Companion Diagnostics (CDx) Development Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Companion Diagnostics (CDx) Development Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Companion Diagnostics (CDx) Development Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Companion Diagnostics (CDx) Development Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Feasibility Studies, Assay Development).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Companion Diagnostics (CDx) Development Services market.
Regional Analysis: The report involves examining the Companion Diagnostics (CDx) Development Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Companion Diagnostics (CDx) Development Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Companion Diagnostics (CDx) Development Services:
Company Analysis: Report covers individual Companion Diagnostics (CDx) Development Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Companion Diagnostics (CDx) Development Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Diseases, Neurological Disorders).
Technology Analysis: Report covers specific technologies relevant to Companion Diagnostics (CDx) Development Services. It assesses the current state, advancements, and potential future developments in Companion Diagnostics (CDx) Development Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Companion Diagnostics (CDx) Development Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Companion Diagnostics (CDx) Development Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others
Market segment by Application
Infectious Diseases
Neurological Disorders
Market segment by players, this report covers
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q² Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Companion Diagnostics (CDx) Development Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Companion Diagnostics (CDx) Development Services, with revenue, gross margin and global market share of Companion Diagnostics (CDx) Development Services from 2019 to 2024.
Chapter 3, the Companion Diagnostics (CDx) Development Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Companion Diagnostics (CDx) Development Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostics (CDx) Development Services.
Chapter 13, to describe Companion Diagnostics (CDx) Development Services research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Companion Diagnostics (CDx) Development Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Diagnostics (CDx) Development Services by Type
1.3.1 Overview: Global Companion Diagnostics (CDx) Development Services Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Type in 2023
1.3.3 Feasibility Studies
1.3.4 Assay Development
1.3.5 Analytical Validation
1.3.6 Clinical Validation
1.3.7 Others
1.4 Global Companion Diagnostics (CDx) Development Services Market by Application
1.4.1 Overview: Global Companion Diagnostics (CDx) Development Services Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infectious Diseases
1.4.3 Neurological Disorders
1.5 Global Companion Diagnostics (CDx) Development Services Market Size & Forecast
1.6 Global Companion Diagnostics (CDx) Development Services Market Size and Forecast by Region
1.6.1 Global Companion Diagnostics (CDx) Development Services Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Companion Diagnostics (CDx) Development Services Market Size by Region, (2019-2030)
1.6.3 North America Companion Diagnostics (CDx) Development Services Market Size and Prospect (2019-2030)
1.6.4 Europe Companion Diagnostics (CDx) Development Services Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size and Prospect (2019-2030)
1.6.6 South America Companion Diagnostics (CDx) Development Services Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Companion Diagnostics (CDx) Development Services Market Size and Prospect (2019-2030)
2.1 Geneuity-Clinical Research Services
2.1.1 Geneuity-Clinical Research Services Details
2.1.2 Geneuity-Clinical Research Services Major Business
2.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product and Solutions
2.1.4 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Geneuity-Clinical Research Services Recent Developments and Future Plans
2.2 Interpace Biosciences
2.2.1 Interpace Biosciences Details
2.2.2 Interpace Biosciences Major Business
2.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Product and Solutions
2.2.4 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Interpace Biosciences Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Companion Diagnostics (CDx) Development Services Product and Solutions
2.3.4 Labcorp Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 Quest Diagnostics
2.4.1 Quest Diagnostics Details
2.4.2 Quest Diagnostics Major Business
2.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Product and Solutions
2.4.4 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Quest Diagnostics Recent Developments and Future Plans
2.5 Q² Solutions
2.5.1 Q² Solutions Details
2.5.2 Q² Solutions Major Business
2.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Product and Solutions
2.5.4 Q² Solutions Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Q² Solutions Recent Developments and Future Plans
2.6 ResearchDx
2.6.1 ResearchDx Details
2.6.2 ResearchDx Major Business
2.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Product and Solutions
2.6.4 ResearchDx Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 ResearchDx Recent Developments and Future Plans
2.7 Almac Diagnostic Services
2.7.1 Almac Diagnostic Services Details
2.7.2 Almac Diagnostic Services Major Business
2.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product and Solutions
2.7.4 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Almac Diagnostic Services Recent Developments and Future Plans
2.8 Biocartis
2.8.1 Biocartis Details
2.8.2 Biocartis Major Business
2.8.3 Biocartis Companion Diagnostics (CDx) Development Services Product and Solutions
2.8.4 Biocartis Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Biocartis Recent Developments and Future Plans
2.9 Cerba Research
2.9.1 Cerba Research Details
2.9.2 Cerba Research Major Business
2.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Product and Solutions
2.9.4 Cerba Research Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Cerba Research Recent Developments and Future Plans
2.10 Eurofins Scientific
2.10.1 Eurofins Scientific Details
2.10.2 Eurofins Scientific Major Business
2.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Product and Solutions
2.10.4 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eurofins Scientific Recent Developments and Future Plans
2.11 MLM Medical Labs
2.11.1 MLM Medical Labs Details
2.11.2 MLM Medical Labs Major Business
2.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Product and Solutions
2.11.4 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MLM Medical Labs Recent Developments and Future Plans
2.12 Qiagen
2.12.1 Qiagen Details
2.12.2 Qiagen Major Business
2.12.3 Qiagen Companion Diagnostics (CDx) Development Services Product and Solutions
2.12.4 Qiagen Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Qiagen Recent Developments and Future Plans
2.13 BGI Genomics
2.13.1 BGI Genomics Details
2.13.2 BGI Genomics Major Business
2.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Product and Solutions
2.13.4 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 BGI Genomics Recent Developments and Future Plans
2.14 MEDx Translational Medicine
2.14.1 MEDx Translational Medicine Details
2.14.2 MEDx Translational Medicine Major Business
2.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product and Solutions
2.14.4 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 MEDx Translational Medicine Recent Developments and Future Plans
2.15 Medical Biological Laboratories (MBL)
2.15.1 Medical Biological Laboratories (MBL) Details
2.15.2 Medical Biological Laboratories (MBL) Major Business
2.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product and Solutions
2.15.4 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Medical Biological Laboratories (MBL) Recent Developments and Future Plans
2.16 Novogene
2.16.1 Novogene Details
2.16.2 Novogene Major Business
2.16.3 Novogene Companion Diagnostics (CDx) Development Services Product and Solutions
2.16.4 Novogene Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Novogene Recent Developments and Future Plans
3.1 Global Companion Diagnostics (CDx) Development Services Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Companion Diagnostics (CDx) Development Services by Company Revenue
3.2.2 Top 3 Companion Diagnostics (CDx) Development Services Players Market Share in 2023
3.2.3 Top 6 Companion Diagnostics (CDx) Development Services Players Market Share in 2023
3.3 Companion Diagnostics (CDx) Development Services Market: Overall Company Footprint Analysis
3.3.1 Companion Diagnostics (CDx) Development Services Market: Region Footprint
3.3.2 Companion Diagnostics (CDx) Development Services Market: Company Product Type Footprint
3.3.3 Companion Diagnostics (CDx) Development Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Companion Diagnostics (CDx) Development Services Consumption Value and Market Share by Type (2019-2024)
4.2 Global Companion Diagnostics (CDx) Development Services Market Forecast by Type (2025-2030)
5.1 Global Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Application (2019-2024)
5.2 Global Companion Diagnostics (CDx) Development Services Market Forecast by Application (2025-2030)
6.1 North America Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2030)
6.2 North America Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2030)
6.3 North America Companion Diagnostics (CDx) Development Services Market Size by Country
6.3.1 North America Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2030)
6.3.2 United States Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
6.3.3 Canada Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
6.3.4 Mexico Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
7.1 Europe Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2030)
7.2 Europe Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2030)
7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Country
7.3.1 Europe Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2030)
7.3.2 Germany Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
7.3.3 France Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
7.3.5 Russia Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
7.3.6 Italy Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Region (2019-2030)
8.3.2 China Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
8.3.3 Japan Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
8.3.4 South Korea Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
8.3.5 India Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
8.3.7 Australia Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
9.1 South America Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2030)
9.2 South America Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2030)
9.3 South America Companion Diagnostics (CDx) Development Services Market Size by Country
9.3.1 South America Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
9.3.3 Argentina Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
10.3.4 UAE Companion Diagnostics (CDx) Development Services Market Size and Forecast (2019-2030)
11.1 Companion Diagnostics (CDx) Development Services Market Drivers
11.2 Companion Diagnostics (CDx) Development Services Market Restraints
11.3 Companion Diagnostics (CDx) Development Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Companion Diagnostics (CDx) Development Services Industry Chain
12.2 Companion Diagnostics (CDx) Development Services Upstream Analysis
12.3 Companion Diagnostics (CDx) Development Services Midstream Analysis
12.4 Companion Diagnostics (CDx) Development Services Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Companion Diagnostics (CDx) Development Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Companion Diagnostics (CDx) Development Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Companion Diagnostics (CDx) Development Services Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Companion Diagnostics (CDx) Development Services Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Geneuity-Clinical Research Services Company Information, Head Office, and Major Competitors
Table 6. Geneuity-Clinical Research Services Major Business
Table 7. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product and Solutions
Table 8. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Geneuity-Clinical Research Services Recent Developments and Future Plans
Table 10. Interpace Biosciences Company Information, Head Office, and Major Competitors
Table 11. Interpace Biosciences Major Business
Table 12. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product and Solutions
Table 13. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Interpace Biosciences Recent Developments and Future Plans
Table 15. Labcorp Company Information, Head Office, and Major Competitors
Table 16. Labcorp Major Business
Table 17. Labcorp Companion Diagnostics (CDx) Development Services Product and Solutions
Table 18. Labcorp Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Labcorp Recent Developments and Future Plans
Table 20. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 21. Quest Diagnostics Major Business
Table 22. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product and Solutions
Table 23. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Quest Diagnostics Recent Developments and Future Plans
Table 25. Q² Solutions Company Information, Head Office, and Major Competitors
Table 26. Q² Solutions Major Business
Table 27. Q² Solutions Companion Diagnostics (CDx) Development Services Product and Solutions
Table 28. Q² Solutions Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Q² Solutions Recent Developments and Future Plans
Table 30. ResearchDx Company Information, Head Office, and Major Competitors
Table 31. ResearchDx Major Business
Table 32. ResearchDx Companion Diagnostics (CDx) Development Services Product and Solutions
Table 33. ResearchDx Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. ResearchDx Recent Developments and Future Plans
Table 35. Almac Diagnostic Services Company Information, Head Office, and Major Competitors
Table 36. Almac Diagnostic Services Major Business
Table 37. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product and Solutions
Table 38. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Almac Diagnostic Services Recent Developments and Future Plans
Table 40. Biocartis Company Information, Head Office, and Major Competitors
Table 41. Biocartis Major Business
Table 42. Biocartis Companion Diagnostics (CDx) Development Services Product and Solutions
Table 43. Biocartis Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Biocartis Recent Developments and Future Plans
Table 45. Cerba Research Company Information, Head Office, and Major Competitors
Table 46. Cerba Research Major Business
Table 47. Cerba Research Companion Diagnostics (CDx) Development Services Product and Solutions
Table 48. Cerba Research Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Cerba Research Recent Developments and Future Plans
Table 50. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 51. Eurofins Scientific Major Business
Table 52. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product and Solutions
Table 53. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Eurofins Scientific Recent Developments and Future Plans
Table 55. MLM Medical Labs Company Information, Head Office, and Major Competitors
Table 56. MLM Medical Labs Major Business
Table 57. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product and Solutions
Table 58. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. MLM Medical Labs Recent Developments and Future Plans
Table 60. Qiagen Company Information, Head Office, and Major Competitors
Table 61. Qiagen Major Business
Table 62. Qiagen Companion Diagnostics (CDx) Development Services Product and Solutions
Table 63. Qiagen Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Qiagen Recent Developments and Future Plans
Table 65. BGI Genomics Company Information, Head Office, and Major Competitors
Table 66. BGI Genomics Major Business
Table 67. BGI Genomics Companion Diagnostics (CDx) Development Services Product and Solutions
Table 68. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. BGI Genomics Recent Developments and Future Plans
Table 70. MEDx Translational Medicine Company Information, Head Office, and Major Competitors
Table 71. MEDx Translational Medicine Major Business
Table 72. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product and Solutions
Table 73. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. MEDx Translational Medicine Recent Developments and Future Plans
Table 75. Medical Biological Laboratories (MBL) Company Information, Head Office, and Major Competitors
Table 76. Medical Biological Laboratories (MBL) Major Business
Table 77. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product and Solutions
Table 78. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Medical Biological Laboratories (MBL) Recent Developments and Future Plans
Table 80. Novogene Company Information, Head Office, and Major Competitors
Table 81. Novogene Major Business
Table 82. Novogene Companion Diagnostics (CDx) Development Services Product and Solutions
Table 83. Novogene Companion Diagnostics (CDx) Development Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Novogene Recent Developments and Future Plans
Table 85. Global Companion Diagnostics (CDx) Development Services Revenue (USD Million) by Players (2019-2024)
Table 86. Global Companion Diagnostics (CDx) Development Services Revenue Share by Players (2019-2024)
Table 87. Breakdown of Companion Diagnostics (CDx) Development Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Companion Diagnostics (CDx) Development Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Companion Diagnostics (CDx) Development Services Players
Table 90. Companion Diagnostics (CDx) Development Services Market: Company Product Type Footprint
Table 91. Companion Diagnostics (CDx) Development Services Market: Company Product Application Footprint
Table 92. Companion Diagnostics (CDx) Development Services New Market Entrants and Barriers to Market Entry
Table 93. Companion Diagnostics (CDx) Development Services Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Companion Diagnostics (CDx) Development Services Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Companion Diagnostics (CDx) Development Services Consumption Value Share by Type (2019-2024)
Table 96. Global Companion Diagnostics (CDx) Development Services Consumption Value Forecast by Type (2025-2030)
Table 97. Global Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2024)
Table 98. Global Companion Diagnostics (CDx) Development Services Consumption Value Forecast by Application (2025-2030)
Table 99. North America Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Companion Diagnostics (CDx) Development Services Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Companion Diagnostics (CDx) Development Services Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Companion Diagnostics (CDx) Development Services Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Companion Diagnostics (CDx) Development Services Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Companion Diagnostics (CDx) Development Services Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Companion Diagnostics (CDx) Development Services Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Companion Diagnostics (CDx) Development Services Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Companion Diagnostics (CDx) Development Services Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Companion Diagnostics (CDx) Development Services Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Companion Diagnostics (CDx) Development Services Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Companion Diagnostics (CDx) Development Services Raw Material
Table 130. Key Suppliers of Companion Diagnostics (CDx) Development Services Raw Materials
List of Figures
Figure 1. Companion Diagnostics (CDx) Development Services Picture
Figure 2. Global Companion Diagnostics (CDx) Development Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Type in 2023
Figure 4. Feasibility Studies
Figure 5. Assay Development
Figure 6. Analytical Validation
Figure 7. Clinical Validation
Figure 8. Others
Figure 9. Global Companion Diagnostics (CDx) Development Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Application in 2023
Figure 11. Infectious Diseases Picture
Figure 12. Neurological Disorders Picture
Figure 13. Global Companion Diagnostics (CDx) Development Services Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Companion Diagnostics (CDx) Development Services Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Companion Diagnostics (CDx) Development Services Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Region in 2023
Figure 18. North America Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Companion Diagnostics (CDx) Development Services Revenue Share by Players in 2023
Figure 24. Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Companion Diagnostics (CDx) Development Services Market Share in 2023
Figure 26. Global Top 6 Players Companion Diagnostics (CDx) Development Services Market Share in 2023
Figure 27. Global Companion Diagnostics (CDx) Development Services Consumption Value Share by Type (2019-2024)
Figure 28. Global Companion Diagnostics (CDx) Development Services Market Share Forecast by Type (2025-2030)
Figure 29. Global Companion Diagnostics (CDx) Development Services Consumption Value Share by Application (2019-2024)
Figure 30. Global Companion Diagnostics (CDx) Development Services Market Share Forecast by Application (2025-2030)
Figure 31. North America Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 41. France Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Region (2019-2030)
Figure 48. China Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 51. India Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Companion Diagnostics (CDx) Development Services Consumption Value (2019-2030) & (USD Million)
Figure 65. Companion Diagnostics (CDx) Development Services Market Drivers
Figure 66. Companion Diagnostics (CDx) Development Services Market Restraints
Figure 67. Companion Diagnostics (CDx) Development Services Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Companion Diagnostics (CDx) Development Services in 2023
Figure 70. Manufacturing Process Analysis of Companion Diagnostics (CDx) Development Services
Figure 71. Companion Diagnostics (CDx) Development Services Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Geneuity-Clinical Research Services Interpace Biosciences Labcorp Quest Diagnostics Q² Solutions ResearchDx Almac Diagnostic Services Biocartis Cerba Research Eurofins Scientific MLM Medical Labs Qiagen BGI Genomics MEDx Translational Medicine Medical Biological Laboratories (MBL) Novogene
Related Reports
06 Feb 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
